PROCEPT BioRobotics Corporation - stock earnings
PRCT Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | -0.51 / -0.57 | - | 44.5 million / 42.4 million | - |
| July 25, 2024 BeforeMarket | - / - | 49.6 million | - / 50.2 million | 51.0 million |
PRCT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -26.0 million USD | 44.5 million USD |
| 2023Q4 | -27.5 million USD | 43.6 million USD |
| 2023Q3 | -24.6 million USD | 35.1 million USD |
| 2023Q2 | -25.3 million USD | 33.1 million USD |
| 2023Q1 | -27.7 million USD | 24.4 million USD |
| 2022Q4 | -31.3 million USD | 23.8 million USD |
| 2022Q3 | -23.1 million USD | 20.3 million USD |
| 2022Q2 | -20.5 million USD | 16.7 million USD |
| 2022Q1 | -18.7 million USD | 14.2 million USD |
| 2021Q4 | -18.3 million USD | 10.1 million USD |
| 2021Q3 | -14.1 million USD | 8.7 million USD |
| 2021Q2 | -14.6 million USD | 8.5 million USD |
| 2021Q1 | -12.8 million USD | 7.2 million USD |
| 2020Q4 | -15.3 million USD | 3.2 million USD |
| 2020Q3 | -12.0 million USD | 2.1 million USD |
| 2020Q2 | -12.9 million USD | 1.2 million USD |
| 2020Q1 | -12.9 million USD | 1.2 million USD |
PRCT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -105.9 million USD | 136.2 million USD |
| 2022 | -93.6 million USD | 75.0 million USD |
| 2021 | -62.4 million USD | 34.5 million USD |
| 2020 | -58.3 million USD | 7.7 million USD |
| 2019 | -42.7 million USD | 6.2 million USD |
PRCT
Price: $64.31
52 week price:
Earnings Per Share: -2.24 USD
P/E Ratio: -20.70
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 249300
Market Capitalization: 3.3 billion